Dr. Jeffrey Prichard
JEFFREY W. PRICHARD, DO
Anatomic Pathology, Clinical Pathology
100 North Academy Avenue
Danville, PA 17822-0131
1 800 695 6491
Dr. Prichard is an Associate of Geisinger Medical Laboratories at Geisinger
Medical Center.
Education:
He received his D.O. from Kirksville College of Osteopathic
Medicine in Kirksville, Missouri, and completed an internship at Metro
Health Center in Erie. He performed his residency in Anatomic and Clinical
Pathology
and fellowship training in Anatomic Pathology at Allegheny General Hospital
in Pittsburgh.
Certifications:
Dr. Prichard is board-certified by the American Board
of Pathology in both anatomic and clinical pathology, as well as by the
National Board
of Osteopathic Medical Examiners. He specializes in breast and gynecologic
pathology, liver pathology, and renal pathology.
Reseach Interests:
Anatomic pathology
and medical informatics, image analysis, and quantitative immunohistochemistry.
Publications in Peer-Reviewed Journals:
Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW, Brown RE, Zhang J, Wang HL, Schuerch C. Diagnostic Utility of S100P and von Hippel-Lindau Gene Product (pVHL) in Pancreatic Adenocarcinoma-With Implication of Their Roles in Early Tumorigenesis. Am G Surg Pathol
32. 78-91, 2008. Prichard JW, Strevig G, Brown AM, Wilkerson M. Informatics tools for quality in anatomic pathology. Clin Lab Med
28. 207-222, 2008. Prichard JW, Strevig G, Brown AM, Wilkerson M. Informatics tools for quality in anatomic pathology. Clin Lab Med
28. 207-222, 2008. Zhang K, Prichard JW, Yoder S, Jitakshi D, Lin F. Utility of SKP2 and MIB-1 in grading follicular lymphoma
using quantitative imaging analysis. Human Pathol
38. 878-882, 2007. Patel Aa, Gilbertson Jr, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard JW, Wilkerson M, Herbermann RB, Becich Mj, and the PCABC. A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform
3. 255-274, 2007. Brown RE, Tan D, Taylor JS, Miller M, Prichard JW, Kott MM. Confirmation of Constitutively Activated mTOR, ERK and NF-kappaB Pathways in High Risk Neuroblastoma with Cell Cycle and Protein Analyte Correlates. Ann Clin Lab Sci
Spring. 37, 2007. Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathways in renal cell carcinomas. Ann Clin Lab Sci
36. 283-293, 2006. Zhang P, Prichard JW, Lin F, Shultz SK, Malek SK, Shaw JH, Hartle JE. Chronic active thrombotic microangiopathy in native and transplanted kidneys. Ann Clin Lab Sci
36. 319-325, 2006. Siegelmann-Danieli N, Khandwlwal V, Wood GC, Mainali R, Prichard JW, Murphy TJ, Evans JF, Yumen O, Bernath AM. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer
7. 59-66, 2006. Lin F, Zhang PL, Prichard JW, Lun MY, Brown RE. Overexpressed and activated mTOR pathway in renal cell carcinomas. Ann Clin Lab Sci
36. 283-293, 2006. Brown RE, Prichard JW, Lin F. Morphoproteomic study of the mTOR pathway in renal cell carcinoma. Ann Clin Lab Sci
36. 283-293, 2006. Zhang K, Prichard JW, Brown RE. Blastic Natural Killer (NK) Cell Leukemia (Agranular CD4+CD56+ Leukemia). Ann Clin Lab Sci
36. 212-215, 2006. Lin F, Zhang XH, Jang JW, Prichard JW. Overexpressed and Activated mTOR Pathway in Renal Cell Carcinomas. Ann Clin Lab Sci
126. 79-85, 2006. Zhang PL, Yahya TM, Prichard JW, Shaw IV, Hartle JE,Lin F, Schwartzman MS. Case report: IgM type of membranous glomerulopathy in a diabetic patient. Ann Clin Lab Sci
35. 113-224, 2005. Zhang PL, Malek SK, Prichard JW, Lin F, Tahya TM, Schwartzman MS, Latsha RP, Norfolk ER, Blasick TM, Lun M, Brown RE, Hartle JE, Potdar S. Acute cellular rejection predominated by monocytes is a severe form of rejection in human recipients with or without Campath-1H (alemtuzumab) induction therapy. Am J Transplant
5. 604-607, 2005. Zhang PL, Yahya TM, Prichard JW, John H. Shaw IV, Hartle JE, Lin F, Schwartzman MS. Case report: IgM type of membranous glomerulopathy in a diabetic patient. Ann Clin Lab Sci
35. 113-124, 2005. Fisher ER, Anderson S, Dean S, Dabbs D, Fisher B, Siderits R, Prichard JW, J, Pereira T, Geyer C, Wolmark N. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer
103. 164-173, 2005. Siegelmann-Danieli N, Murphy TJ, Meschter SC, Stein ME, Prichard JW. Primary pure squamous cell carcinoma of the breast
. Clin Breast Cancer
6. 270-272, 2005. Lin F, Shen T, Prichard JW. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens. Diag Cytopathol
33. 376-380, 2005. Lin F, Zhang K, Quiery AT, Prichard J, Schuerch C. Plasmablastic lymphoma of the cervical lymph node in an HIV-negative patient – A case report and review of the literature. Arch Pathol Lab Med
128. 581-584, 2004. Zhang PL, Malek SK, Prichard JW, Lin F, Yahya TM, Schwartzman MS, Latsha RP, Skaletsky M, Norfolk ER, Brown RE, Hartle JE, Potdar S. Monocyte mediated acute renal rejection after combined treatment with preoperative campath-1H (Aleumtuzuman) and postoperative immunosuppression. Ann Clin Lab Sci
34. 209-213, 2004. Brown RE, Lun M, Prichard JW, Blasick TM, Zhang PL. Morphoproteomic and Pharmacoproteomic Correlates in Hormone-Receptor-Negative Breast Carcinoma Cell Lines. Ann Clin Lab Sci
34. 261-261, 2004.
Presentations
Zhang PL, Malek SK, Lin F, Blasick TM, Prichard JW, et al. Inflammatory Cells Involved in Acute Renal Rejection in Humans Show a Large Variation for CD52 Expre.
Abstract. American Transplant Congress Meeting, Seattle, WA,
05/21/2005 - 05/25/2005.
Wilkerson M, Brown A, Prichard J, Strevig G. GML PORT: A relational database for pathology research.
E-poster. APIII 2004, Association for Pathology Informatics, Pittsburgh, PA,
10/01/2004.
Zhang K , Prichard JW and Lin F. Utility of Skp-2 and MIB-1 in Grading Follicular Lymphoma Using Quantitative Image Analysis.
Poster Presentation. USCAP Annual Meeting, San Antonio, TX,
2005.
Zhang PL, Malek SK, Schwarwtzman MS, Schultz MF, Lin F, Prichard JW, Norfolk ER, Yahya TM, Pennington JR, Hartle JE, Potdar S. Low CD52 expression in inflammatory cells involved in acute renal rejection in humans after Campath-1H induction correlates with better treatment response.
Abstract. J am Soc Nephrol 16, 234A,
2005.
Liu H, Lin F, Prichard JW. Sensitivity and Specificity of Immunohistochemical (IHC) detection of ER and PR in Breast Carcinoma on Cell Block Cytology by Quantitative Image Analysis (QIA).
Abstract. Modern Pathol 19, 284,
2006.
Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Bernath AM. Breast cancer in elderly women: combined effect of tumor features, age, co-morbidities and treatment.
Abstract. 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX,
December 2005.
Zhang PL, Lin F, Prichard JW, Malek SK, Tahya TM, Schwartzman MS, Norfolk ER, Brown RE, Hartle JE, Potdar S. Acute Renal Rejection Predominated by Monocytes is a Severe Form of Rejection in Human Recipients.
Abstract #1257. USCAP Annual Meeting, San Antonio, TX,
February 2005.
Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE. Overexpressed and activated mTOR pathway in renal cell carcinoma.
Abstract #705. USCAP Annual Meeting, San Antonio, TX,
February 2005.
Zhang PL, Malek SK, Blasick TM, Lin F, Prichard JW, Pennington JR, Schultz MF, Yahya TM, Norfolk ER, Hartle JE, Potdar S. C4d positivity is low in protocol renal transplant biopsies and indicated biopsies with acute tubular necrosis, but high in indicated biopsies with acute cellular rejection following intraoperative Campath-1H induction and post-operative immunosuppression.
Abstract #1200. World Transplant Congress, Boston, MA,
July 22-27, 2006.
Liu H,Jianhui Shi, Jun Zhang, Prichard JW,Dupree W Lin F. The von Hippel-Lindau gene product (pVHL): A diagnostic marker for clear cell carcinoma of the ovary and uterus.
Abstract. USCAP Meeting, Denver, CO,
March 1-7,2008.
Brown RE, Tan D, Hunter RL, Prichard JW, Taylor J. Morphoproteomic Confirmation of Constitutively Activated mTOR, ERK and NF-kappaB Pathways in High Risk Neuroblastoma with Cell Cycle and Protein Analyte Correlates: A Preliminary Study.
Abstract. United States and Canadian Acadmey of Pathology 96th Annual Meeting, San Diego, CA,
March 24-30, 2007.
Lin F, Wang HL, Shi J, Prichard JW, Brown RE, Hull M, Schuerch C. Expression of S100A4, S100A6, and S100P in Pancreatic and Ampullary Adenocarcinomas.
Abstract. United States and Canadian Academy of Pathology 96th Annual Meeting, San Diego, CA,
March 24-30, 2007.
Miller M, Schworer CW, Brown RE, Prichard JW, Wilkerson M, Bonventre JV, Lin F, Zhang PL, Ramdas J. Identifying the Origin and Therapeutic Target in Wilms' Tumor.
Abstract #1534. 21st Annual Meeting of the American Society of Pediatric Hematology/Oncology, Cincinnati, OH,
May 15, 2008.
Prichard JW. Applying Statistical Quality Control to Her-2/neu Oncoprotein Immunohistochemistry.
Poster/Presentation. Meeting of the Association of Clinical Scientists, Los Angeles, CA,
May 18, 2008.
Prichard JW. Morphoproteomics: Digital Image Management and Image Analysis. 125th Meeting of the Association of C.
Abstract and Podium Presentation. 125th Meeting of the Association of Clinical Scientists, Troy, MI,
May 2005.
Prichard JW. Immunocytochemistry of Hormone Receptors in Breast Cancer.
Abstract and Podium Presentation. 126th Meeting of the Association of Clinical Scientists, Amelia Island, FL,
May 2006.
Zhang K, Yang XJ, Prichard JW, Lun M, Brown RE. Blastic NK cell leukemia.
Poster. 2004 Clinical Flow Cytometry Meeting, Long Beach, CA,
October 15-17,2004.
P L. Zhang, R Mainali, Glenn H. Bock, Lin F, Prichard JW, J E. Hartle, and J V. Bonventre. Human Kidney Injury Molecule-1 (KIM-1) Expression Helps Identify Tubular Injury in Renal Biopsies from Uncommon Renal Diseases.
Presentation. American Society of Nephrology Renal Week, San Francisco, CA ,
October 31-November 5, 2007.
|